|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Costs and expenses: | |||||
| Cost of revenues | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Restructuring charges | |||||
| Depreciation and amortization | |||||
| Total costs and expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Gain on sale of DXP | |||||
| Other income (expense), net | |||||
| Income (loss) from continuing operations, before taxes | |||||
| (Provision) benefit for income taxes | |||||
| Net income (loss) from continuing operations | |||||
| Net income from discontinued operations, net of tax | |||||
| Discontinued operations (Note 4): | |||||
| (Loss) income from discontinued operations, before taxes | |||||
| Loss on divestiture | |||||
| Provision for income taxes | |||||
| Net loss from discontinued operations | |||||
| Net income (loss) | |||||
| Net income (loss) attributable to redeemable non-controlling interests | |||||
| Preferred stock dividend, net of gain on repurchase of preferred stock | |||||
| Net income (loss) attributable to Synchronoss | |||||
| Earnings (loss) per share: | |||||
| Basic: | |||||
| Net income (loss) from continuing operations (in dollars per share) | |||||
| Net loss from discontinued operations (in dollars per share) | |||||
| Basic (in dollars per share) | |||||
| Diluted: | |||||
| Net income (loss) from continuing operations (in dollars per share) | |||||
| Net loss from discontinued operations (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...